Cargando…

Choosing an insulin injector by a structured, pharmaceutical-neutral curriculum via an informed shared decision-making process in 349 insulin-naive patients with diabetes mellitus

BACKGROUND: The national guideline for diabetes type 2 claims to involve patients in their decision-making on therapy. Unfortunately, no structured, pharmaceutical-neutral curriculum is available to guide patients in this shared decision-making (SDM) process regarding the insulin injector. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mertes, Bernardo, Gödde, Sybille, Kloos, Christof, Kuniß, Nadine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290035/ https://www.ncbi.nlm.nih.gov/pubmed/37005930 http://dx.doi.org/10.1007/s00592-023-02069-0

Ejemplares similares

Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years
por: Mertes, Bernardo, et al.
Publicado: (2020)

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
por: Kramer, Guido, et al.
Publicado: (2021)

Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes
por: Pohlmeier, Harald, et al.
Publicado: (2017)

Diabetes related distress is high in inpatients with diabetes
por: Kuniss, Nadine, et al.
Publicado: (2021)

Insulin for type 2 diabetes: choosing a second-line insulin regimen
por: Barnett, A, et al.
Publicado: (2008)

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes
por: Home, P D, et al.
Publicado: (2015)

Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance
por: Nakamura, Yuko, et al.
Publicado: (2020)

The accuracy and precision of insulin administration using human and veterinary pen‐injectors and syringes for administration of insulin
por: Malerba, Eleonora, et al.
Publicado: (2021)

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens
por: Yavuz, Dilek Gogas, et al.
Publicado: (2015)

Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
por: Guo, Lixin, et al.
Publicado: (2017)

Health Tract No. 349: Healthful Atmosphere
Publicado: (1868)

Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
por: Schneider, John E., et al.
Publicado: (2018)

Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review
por: Sparre, Thomas, et al.
Publicado: (2022)

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
por: Davies, M. J., et al.
Publicado: (2016)

MD 349: Impedance Localization with AC-dipole
por: Biancacci, Nicolo, et al.
Publicado: (2016)

Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients
por: Ling, James, et al.
Publicado: (2021)

Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
por: Yki-Järvinen, Hannele, et al.
Publicado: (2013)

Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
por: Bue-Valleskey, Juliana M., et al.
Publicado: (2023)

A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
por: Bonafede, Machaon MK, et al.
Publicado: (2010)

349. Implementation of a Multidisciplinary HIV-Pulmonary Clinic
por: Sellers, Subhashini A, et al.
Publicado: (2019)

SUN-349 Characterizing Functional Performance in Adults with Hypophosphatasia
por: Dahir, Kathryn, et al.
Publicado: (2020)

Metabolic syndrome in drug-naïve Chinese patients with insulin-sensitive and insulin-resistant type 2 diabetes
por: Lin, Jiunn-Diann, et al.
Publicado: (2016)

Sensing of chlorpheniramine in pharmaceutical applications by sequential injector coupled with potentiometer
por: Saleh, Tawfik A.
Publicado: (2011)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
por: Rodbard, H W, et al.
Publicado: (2013)

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
por: Rodbard, H W, et al.
Publicado: (2014)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)

Randomized Crossover Study to Examine the Necessity of an Injection-to-Meal Interval in Patients With Type 2 Diabetes and Human Insulin
por: Müller, Nicolle, et al.
Publicado: (2013)

Lilly Insulin Glargine Versus Lantus(®) in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
por: Pollom, Robyn K., et al.
Publicado: (2019)

Drift Chamber Track Reconstruction for the P349 Antiproton Experiment
por: Alfs, Dominika
Publicado: (2017)

Drift chamber calibration and particle identification in the P-349 experiment
por: Alfs, D, et al.
Publicado: (2019)

Phosphorylation of serine 349 of p62 in Alzheimer’s disease brain
por: Tanji, Kunikazu, et al.
Publicado: (2014)

Sequence analysis of the gliding protein Gli349 in Mycoplasma mobile
por: Metsugi, Shoichi, et al.
Publicado: (2005)

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019)

349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19
por: Groft, Lauren, et al.
Publicado: (2021)

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
por: Naegeli, A N, et al.
Publicado: (2010)

UV-Light Exposure of Insulin: Pharmaceutical Implications upon Covalent Insulin Dityrosine Dimerization and Disulphide Bond Photolysis
por: Correia, Manuel, et al.
Publicado: (2012)

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
por: Pan, Changyu, et al.
Publicado: (2016)

Abstract 5: Similar hypoglycemia duration with once-weekly insulin icodec versus insulin glargine U100 in insulin naïve or experienced patients with T2D
por: Manjunath, Aparna, et al.
Publicado: (2022)

The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
por: Pan, Qi, et al.
Publicado: (2022)

Quasistationary Arc Plasma Generator for Diagnostic Neutral Beam Injector
por: Stupishin, N V, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_gbthr3vnu58dv3l2fsugm7td63